Literature DB >> 11091591

Inflammatory Carcinoma of the Breast: Characteristic Findings of MR Imaging.

.   

Abstract

Inflammatory breast carcinoma (IBC) Shows a unique clinical appearance and has an extremely poor prognosis. Although immediate intensive therapy has been proposed, diagnosis of this disease tends to be delayed as its clinical features can be confused with acute mastitis. The conventional imaging modalities including mammography and ultrasonography are of limited value in the diagnosis of IBC, as it is difficult to delineate specific findings of the swollen dense breast. Recently, magnetic resonance (MR) imaging has been widely applied to breast diseases. One of the excellent features of this modality is its diagnostic ability in dense breasts. However, few trials to evaluate the capability of this new modality for IBC have been documented. In recent years, we found that a characteristic feature in 5 cases of IBC was a strong signal on T2-weighted images (T2WI) of MR imaging at the retromammary and subcutaneous area. Pathological features of the retromammary area showed marked interstitial edema and focal lymphatic involvement by tumor cells. These characteristic images obtained by MR imaging may be suggestive of inflammatroy breast carcinoma. Furthermore, subtracted dynamic MR imaging indicated the site of the tumor. Therefore, the application of MR imaging for swollen breasts would assist in the immediate diagnosis of IBC and would contribute to appropriate and timely therapy.

Entities:  

Year:  1997        PMID: 11091591     DOI: 10.1007/BF02967070

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  3 in total

1.  Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response?

Authors:  J-H Chen; R S Mehta; O Nalcioglu; M-Y Su
Journal:  Ann Surg Oncol       Date:  2008-09-19       Impact factor: 5.344

2.  Inflammatory breast cancer: MR imaging findings.

Authors:  G Carbognin; C Calciolari; V Girardi; L Camera; G Pollini; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2009-12-16       Impact factor: 3.469

3.  Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.

Authors:  Mateusz Opyrchal; Jeffrey L Salisbury; Ianko Iankov; Mathew P Goetz; James McCubrey; Mario W Gambino; Lorenzo Malatino; Giuseppe Puccia; James N Ingle; Evanthia Galanis; Antonino B D'Assoro
Journal:  Int J Oncol       Date:  2014-06-25       Impact factor: 5.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.